Cargando…
Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases
Susceptibility and disease course of COVID-19 among patients with inflammatory bowel diseases (IBD) are unclear and epidemiological data on the topic are still limited. There is some concern that patients with immuno-mediated diseases such as IBD, which are frequently treated with immunosuppressive...
Autores principales: | Corrias, Angelica, Cortes, Gian Mario, Bardanzellu, Flaminia, Melis, Alice, Fanos, Vassilios, Marcialis, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468140/ https://www.ncbi.nlm.nih.gov/pubmed/34572185 http://dx.doi.org/10.3390/children8090753 |
Ejemplares similares
-
Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin
por: Cortes, Gian Mario, et al.
Publicado: (2022) -
Differential diagnosis between syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome in children over 1 year: proposal for a simple algorithm
por: Bardanzellu, Flaminia, et al.
Publicado: (2021) -
COVID-19 and School: To Open or Not to Open, That Is the Question. The First Review on Current Knowledge
por: Busa, Francesco, et al.
Publicado: (2021) -
Thiamine as a Possible Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Encephalopathy
por: Sechi, Gian Pietro, et al.
Publicado: (2021) -
Breast Milk and COVID-19: From Conventional Data to “Omics” Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers
por: Bardanzellu, Flaminia, et al.
Publicado: (2021)